UFP Technologies, Inc. (UFPT)
USD 187.03
(-3.41%)
USD 187.03
(-3.41%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 40.77 Million USD | -19.34% |
| 2022 | 50.54 Million USD | -30.98% |
| 2021 | 73.24 Million USD | 432.47% |
| 2020 | -22.02 Million USD | -3273.51% |
| 2019 | -653 Thousand USD | -102.98% |
| 2018 | 21.9 Million USD | 157.68% |
| 2017 | -37.97 Million USD | -24.51% |
| 2016 | -30.5 Million USD | -9.2% |
| 2015 | -27.93 Million USD | 10.43% |
| 2014 | -31.18 Million USD | 6.8% |
| 2013 | -33.46 Million USD | -41.68% |
| 2012 | -23.61 Million USD | 0.06% |
| 2011 | -23.62 Million USD | -39.55% |
| 2010 | -16.93 Million USD | -146.33% |
| 2009 | -6.87 Million USD | -1400.83% |
| 2008 | -458.01 Thousand USD | 66.58% |
| 2007 | -1.37 Million USD | -117.87% |
| 2006 | 7.67 Million USD | -55.14% |
| 2005 | 17.1 Million USD | 2.63% |
| 2004 | 16.66 Million USD | 4.26% |
| 2003 | 15.98 Million USD | 14.21% |
| 2002 | 13.99 Million USD | -1.42% |
| 2001 | 14.19 Million USD | 4.53% |
| 2000 | 13.57 Million USD | 61.67% |
| 1999 | 8.4 Million USD | 23.53% |
| 1998 | 6.8 Million USD | 4.62% |
| 1997 | 6.5 Million USD | 18.18% |
| 1996 | 5.5 Million USD | 3.77% |
| 1995 | 5.3 Million USD | 32.5% |
| 1994 | 4 Million USD | 185.71% |
| 1993 | 1.4 Million USD | -63.16% |
| 1992 | 3.8 Million USD | 18.75% |
| 1991 | 3.2 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 31.22 Million USD | -13.54% |
| 2024 Q3 | 195.64 Million USD | 577.61% |
| 2024 Q1 | 36.11 Million USD | -11.43% |
| 2023 Q3 | 51.25 Million USD | -0.89% |
| 2023 Q2 | 51.7 Million USD | -3.34% |
| 2023 Q1 | 53.49 Million USD | 5.83% |
| 2023 FY | 40.77 Million USD | -19.34% |
| 2023 Q4 | 40.77 Million USD | -20.44% |
| 2022 FY | 50.54 Million USD | -30.98% |
| 2022 Q4 | 50.54 Million USD | -31.29% |
| 2022 Q3 | 73.57 Million USD | -31.39% |
| 2022 Q2 | 107.23 Million USD | 6.82% |
| 2022 Q1 | 100.38 Million USD | 37.07% |
| 2021 Q3 | -31.41 Million USD | -10.98% |
| 2021 Q4 | 73.24 Million USD | 333.16% |
| 2021 FY | 73.24 Million USD | 432.47% |
| 2021 Q2 | -28.3 Million USD | -22.44% |
| 2021 Q1 | -23.11 Million USD | -4.93% |
| 2020 Q3 | -15 Million USD | -56.98% |
| 2020 FY | -22.02 Million USD | -3273.51% |
| 2020 Q4 | -22.02 Million USD | -46.79% |
| 2020 Q1 | -4.5 Million USD | -590.2% |
| 2020 Q2 | -9.56 Million USD | -112.11% |
| 2019 Q4 | -653 Thousand USD | -118.09% |
| 2019 Q3 | 3.61 Million USD | -70.4% |
| 2019 Q2 | 12.19 Million USD | -37.93% |
| 2019 Q1 | 19.65 Million USD | -10.29% |
| 2019 FY | -653 Thousand USD | -102.98% |
| 2018 Q3 | 28.76 Million USD | -14.52% |
| 2018 Q1 | 42.22 Million USD | 211.17% |
| 2018 Q2 | 33.65 Million USD | -20.29% |
| 2018 Q4 | 21.9 Million USD | -23.86% |
| 2018 FY | 21.9 Million USD | 157.68% |
| 2017 FY | -37.97 Million USD | -24.51% |
| 2017 Q1 | -33.15 Million USD | -8.69% |
| 2017 Q3 | -37.16 Million USD | -8.75% |
| 2017 Q2 | -34.17 Million USD | -3.07% |
| 2017 Q4 | -37.97 Million USD | -2.2% |
| 2016 Q2 | -25.64 Million USD | -7.56% |
| 2016 Q4 | -30.5 Million USD | -5.16% |
| 2016 Q3 | -29 Million USD | -13.12% |
| 2016 Q1 | -23.84 Million USD | 14.66% |
| 2016 FY | -30.5 Million USD | -9.2% |
| 2015 Q4 | -27.93 Million USD | -2.57% |
| 2015 Q2 | -26.8 Million USD | -23.1% |
| 2015 FY | -27.93 Million USD | 10.43% |
| 2015 Q3 | -27.23 Million USD | -1.61% |
| 2015 Q1 | -21.77 Million USD | 30.18% |
| 2014 Q1 | -31.02 Million USD | 7.29% |
| 2014 FY | -31.18 Million USD | 6.8% |
| 2014 Q4 | -31.18 Million USD | -4.18% |
| 2014 Q3 | -29.93 Million USD | -4.66% |
| 2014 Q2 | -28.6 Million USD | 7.79% |
| 2013 Q3 | -28.94 Million USD | -17.68% |
| 2013 Q2 | -24.59 Million USD | -12.4% |
| 2013 Q1 | -21.88 Million USD | 7.33% |
| 2013 Q4 | -33.46 Million USD | -15.6% |
| 2013 FY | -33.46 Million USD | -41.68% |
| 2012 Q3 | -25.37 Million USD | -8.85% |
| 2012 FY | -23.61 Million USD | 0.06% |
| 2012 Q1 | -21.54 Million USD | 8.83% |
| 2012 Q2 | -23.3 Million USD | -8.2% |
| 2012 Q4 | -23.61 Million USD | 6.92% |
| 2011 FY | -23.62 Million USD | -39.55% |
| 2011 Q1 | -17.89 Million USD | -5.71% |
| 2011 Q4 | -23.62 Million USD | 2.74% |
| 2011 Q3 | -24.29 Million USD | -12.59% |
| 2011 Q2 | -21.57 Million USD | -20.56% |
| 2010 Q1 | -9.16 Million USD | -33.35% |
| 2010 FY | -16.93 Million USD | -146.33% |
| 2010 Q3 | -14.71 Million USD | -28.81% |
| 2010 Q4 | -16.93 Million USD | -15.05% |
| 2010 Q2 | -11.42 Million USD | -24.65% |
| 2009 Q4 | -6.87 Million USD | -86.84% |
| 2009 Q2 | -4.48 Million USD | -404.09% |
| 2009 Q1 | -888.8 Thousand USD | -94.06% |
| 2009 FY | -6.87 Million USD | -1400.83% |
| 2009 Q3 | -3.67 Million USD | 17.89% |
| 2008 Q1 | 4.85 Million USD | 454.46% |
| 2008 FY | -458.01 Thousand USD | 66.58% |
| 2008 Q4 | -458.01 Thousand USD | -140.8% |
| 2008 Q3 | 1.12 Million USD | -54.14% |
| 2008 Q2 | 2.44 Million USD | -49.61% |
| 2007 Q3 | 2.34 Million USD | -61.27% |
| 2007 Q4 | -1.37 Million USD | -158.33% |
| 2007 Q1 | 6.84 Million USD | -10.78% |
| 2007 FY | -1.37 Million USD | -117.87% |
| 2007 Q2 | 6.06 Million USD | -11.37% |
| 2006 Q1 | 15.29 Million USD | -10.56% |
| 2006 Q3 | 10.84 Million USD | -14.07% |
| 2006 Q4 | 7.67 Million USD | -29.28% |
| 2006 FY | 7.67 Million USD | -55.14% |
| 2006 Q2 | 12.62 Million USD | -17.47% |
| 2005 Q1 | 16.66 Million USD | -0.0% |
| 2005 Q4 | 17.1 Million USD | 5.04% |
| 2005 Q2 | 17.06 Million USD | 2.4% |
| 2005 FY | 17.1 Million USD | 2.63% |
| 2005 Q3 | 16.27 Million USD | -4.58% |
| 2004 Q2 | 15.38 Million USD | -1.27% |
| 2004 Q4 | 16.66 Million USD | 4.71% |
| 2004 FY | 16.66 Million USD | 4.26% |
| 2004 Q1 | 15.58 Million USD | -2.5% |
| 2004 Q3 | 15.91 Million USD | 3.43% |
| 2003 Q4 | 15.98 Million USD | -0.25% |
| 2003 FY | 15.98 Million USD | 14.21% |
| 2003 Q1 | 14.33 Million USD | 2.41% |
| 2003 Q3 | 16.02 Million USD | 5.22% |
| 2003 Q2 | 15.22 Million USD | 6.26% |
| 2002 Q3 | 13.49 Million USD | -10.14% |
| 2002 Q4 | 13.99 Million USD | 3.67% |
| 2002 Q2 | 15.02 Million USD | -6.65% |
| 2002 Q1 | 16.09 Million USD | 13.36% |
| 2002 FY | 13.99 Million USD | -1.42% |
| 2001 FY | 14.19 Million USD | 4.53% |
| 2001 Q1 | 16.37 Million USD | 20.61% |
| 2001 Q2 | 15.39 Million USD | -6.04% |
| 2001 Q3 | 15.91 Million USD | 3.41% |
| 2001 Q4 | 14.19 Million USD | -10.81% |
| 2000 FY | 13.57 Million USD | 61.67% |
| 2000 Q1 | 17.05 Million USD | 103.0% |
| 2000 Q2 | 16.46 Million USD | -3.44% |
| 2000 Q3 | 15.72 Million USD | -4.52% |
| 2000 Q4 | 13.57 Million USD | -13.62% |
| 1999 Q2 | 8.3 Million USD | -1.19% |
| 1999 Q4 | 8.4 Million USD | 1.2% |
| 1999 Q3 | 8.3 Million USD | 0.0% |
| 1999 FY | 8.4 Million USD | 23.53% |
| 1999 Q1 | 8.4 Million USD | 23.53% |
| 1998 Q1 | 6.6 Million USD | 1.54% |
| 1998 Q4 | 6.8 Million USD | 51.11% |
| 1998 FY | 6.8 Million USD | 4.62% |
| 1998 Q3 | 4.5 Million USD | -15.09% |
| 1998 Q2 | 5.3 Million USD | -19.7% |
| 1997 Q2 | 6.9 Million USD | -6.76% |
| 1997 Q1 | 7.4 Million USD | 34.55% |
| 1997 Q3 | 6.7 Million USD | -2.9% |
| 1997 Q4 | 6.5 Million USD | -2.99% |
| 1997 FY | 6.5 Million USD | 18.18% |
| 1996 Q3 | 5.1 Million USD | -12.07% |
| 1996 FY | 5.5 Million USD | 3.77% |
| 1996 Q4 | 5.5 Million USD | 7.84% |
| 1996 Q2 | 5.8 Million USD | 0.0% |
| 1996 Q1 | 5.8 Million USD | 9.43% |
| 1995 FY | 5.3 Million USD | 32.5% |
| 1995 Q1 | 3.9 Million USD | -2.5% |
| 1995 Q3 | 4.7 Million USD | 11.9% |
| 1995 Q2 | 4.2 Million USD | 7.69% |
| 1995 Q4 | 5.3 Million USD | 12.77% |
| 1994 Q1 | 2.3 Million USD | 64.29% |
| 1994 FY | 4 Million USD | 185.71% |
| 1994 Q3 | 3.6 Million USD | -5.26% |
| 1994 Q4 | 4 Million USD | 11.11% |
| 1994 Q2 | 3.8 Million USD | 65.22% |
| 1993 Q4 | 1.4 Million USD | 0.0% |
| 1993 FY | 1.4 Million USD | -63.16% |
| 1992 Q4 | 3.8 Million USD | 0.0% |
| 1992 FY | 3.8 Million USD | 18.75% |
| 1991 Q4 | 3.2 Million USD | 0.0% |
| 1991 FY | 3.2 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | -50.558% |
| BrainsWay Ltd. | -10.32 Million USD | 495.097% |
| Cerus Corporation | 84.35 Million USD | 51.662% |
| Envoy Medical, Inc. | -3.81 Million USD | 1169.061% |
| electroCore, Inc. | -9.95 Million USD | 509.583% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 895.59% |
| IceCure Medical Ltd | -9.93 Million USD | 510.449% |
| Inogen, Inc. | -103.56 Million USD | 139.369% |
| OrthoPediatrics Corp. | -9.26 Million USD | 539.991% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 1219.857% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 411.322% |
| MaxCyte, Inc. | -27.76 Million USD | 246.865% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 893.563% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 7181.684% |
| Orthofix Medical Inc. | 96.44 Million USD | 57.722% |
| PAVmed Inc | 29.08 Million USD | -40.184% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 340.711% |
| RxSight, Inc. | -6.68 Million USD | 710.389% |
| Sight Sciences, Inc. | -102.71 Million USD | 139.696% |
| SI-BONE, Inc. | 5.72 Million USD | -612.708% |
| TELA Bio, Inc. | -3.94 Million USD | 1132.515% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 28.867% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -11483.523% |
| Acutus Medical, Inc. | 12.27 Million USD | -232.063% |
| Talis Biomedical Corporation | -57.06 Million USD | 171.453% |
| Spectral AI, Inc. | -3.5 Million USD | 1264.639% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 184.898% |
| CVRx, Inc. | -59.95 Million USD | 168.007% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -1954.991% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -3091.36% |
| Bioventus Inc. | 372.51 Million USD | 89.054% |
| Venus Concept Inc. | 74.3 Million USD | 45.123% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 500.452% |
| LivaNova PLC | 62.53 Million USD | 34.795% |
| 908 Devices Inc. | -115.09 Million USD | 135.426% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 87.286% |
| Nemaura Medical Inc. | 9.92 Million USD | -310.82% |
| NeuroPace, Inc. | 54.33 Million USD | 24.961% |
| LENSAR, Inc. | -18.31 Million USD | 322.663% |
| Apyx Medical Corporation | -5.15 Million USD | 891.574% |
| Cutera, Inc. | 288.3 Million USD | 85.857% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -442.568% |
| BioSig Technologies, Inc. | 262 Thousand USD | -15462.595% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 193.028% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 543.244% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 97.099% |
| Axonics, Inc. | -77.19 Million USD | 152.82% |
| Outset Medical, Inc. | 67.67 Million USD | 39.754% |
| IRIDEX Corporation | -4.28 Million USD | 1050.886% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 122.904% |
| IRadimed Corporation | -47.71 Million USD | 185.446% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 1447.455% |
| INVO Bioscience, Inc. | 8.45 Million USD | -382.468% |
| Telesis Bio, Inc. | 32.63 Million USD | -24.939% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 1729.57% |
| Varex Imaging Corporation | 316.9 Million USD | 87.133% |
| Quipt Home Medical Corp. | 81.73 Million USD | 50.114% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 1565.636% |
| Pulmonx Corporation | -42.36 Million USD | 196.256% |
| Dynatronics Corporation | 6.2 Million USD | -557.218% |
| Modular Medical, Inc. | -8.04 Million USD | 607.013% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 1048.895% |
| Semler Scientific, Inc. | -57.13 Million USD | 171.371% |
| InMode Ltd. | -135.39 Million USD | 130.115% |
| Bruker Corporation | 891.3 Million USD | 95.425% |
| Cytosorbents Corporation | 4.18 Million USD | -874.985% |
| DexCom, Inc. | 2.02 Billion USD | 97.989% |
| Align Technology, Inc. | -840.47 Million USD | 104.851% |
| Viveve Medical, Inc. | -13.81 Million USD | 395.186% |
| ZimVie Inc. | 450.41 Million USD | 90.948% |
| Movano Inc. | -5.86 Million USD | 795.09% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 130.325% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 7181.684% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -1954.991% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 88.572% |
| Profound Medical Corp. | -18.17 Million USD | 324.298% |
| Insulet Corporation | 798.1 Million USD | 94.891% |
| enVVeno Medical Corporation | -2.21 Million USD | 1938.323% |
| Surmodics, Inc. | -12.01 Million USD | 439.387% |
| iCAD, Inc. | -21.2 Million USD | 292.249% |
| Nuwellis, Inc. | -2.81 Million USD | 1546.399% |
| Biotricity, Inc. | 23.09 Million USD | -76.566% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 56.462% |
| Aethlon Medical, Inc. | -4.5 Million USD | 1005.754% |
| InspireMD, Inc. | -8.04 Million USD | 606.824% |
| PAVmed Inc. | 29.08 Million USD | -40.184% |
| BIOLASE, Inc. | 11.34 Million USD | -259.432% |
| Beyond Air, Inc. | 6.22 Million USD | -554.583% |
| FONAR Corporation | -14.66 Million USD | 378.03% |
| AxoGen, Inc. | 32.26 Million USD | -26.368% |
| Vivani Medical, Inc. | 42 Thousand USD | -96980.952% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 482.567% |
| Inari Medical, Inc. | -7.16 Million USD | 669.39% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -1228.739% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 954.566% |
| Tenon Medical, Inc. | -1.25 Million USD | 3348.924% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 636.077% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 441.883% |
| AdaptHealth Corp. | 2.21 Billion USD | 98.161% |
| Sintx Technologies, Inc. | 905 Thousand USD | -4405.414% |
| NanoVibronix, Inc. | -3.27 Million USD | 1343.868% |
| Quanterix Corporation | -132.95 Million USD | 130.667% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 1565.636% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 282.312% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 94.59% |
| TransMedics Group, Inc. | 121.13 Million USD | 66.34% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 255.745% |
| NeuroMetrix, Inc. | -1.49 Million USD | 2834.546% |
| Hyperfine, Inc. | -75.61 Million USD | 153.92% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 73.208% |
| Biomerica, Inc. | -3.38 Million USD | 1304.549% |
| Bone Biologics Corporation | -3.02 Million USD | 1447.202% |
| AVITA Medical, Inc. | -26.23 Million USD | 255.438% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 2317.894% |
| Silk Road Medical, Inc | 64.42 Million USD | 36.709% |